Modivcare's Q4 2024 revenue remained flat at $702.8 million. The company reported a net loss of $23.5 million, significantly higher than the $5.3 million loss in Q4 2023, primarily due to increased service expenses and interest costs. Adjusted EBITDA declined 20.0% year-over-year to $40.4 million, reflecting weaker gross margins. Despite these challenges, the company generated $30.0 million in operating cash flow and secured a $75.0 million incremental term loan to support liquidity.
Revenue remained flat year-over-year at $702.8 million.
Net loss widened to $23.5 million due to higher service costs and interest expenses.
Adjusted EBITDA fell 20.0% to $40.4 million as gross profit declined.
Company secured a $75.0 million term loan to enhance liquidity.
Modivcare expects stabilization in utilization trends and working capital improvements in 2025, with a focus on cost management and operational efficiency.